Saturday, 1 October, 2022
TopicCancer treatment

Topic: Cancer treatment

With ‘re-engineered T-cells’, US firm claims breakthrough in therapy for relapsed multiple myeloma

Pharma giant Bristol Myers Squibb & partner 2seventy bio say they've successfully tested the treatment, which is aimed at stimulating patient’s immune system to act more efficiently.

Fujifilm launches AI-powered health centre in Gurugram that can screen for 10 types of cancer

Known as the NURA health centre, the facility also screens for lifestyle diseases. A full-body screening package at the centre costs Rs 18,000.

Experimental drug shows success in advanced breast cancer patients, better than standard chemo

Trastuzumab deruxtecan helped check cancer growth in even those with low levels of protein that cancer drugs target. Tumours didn't grow for at least 10 months, compared to average 5 in chemotherapy.

A much-awaited cancer ‘miracle’, and the ‘Johnny Depp link’ to resort politics

The best cartoons of the day, chosen by the editors at ThePrint.

Only 7% women, 6% men who have hypertension take medicine, govt’s family health survey shows

The National Family Health Survey 5 data revealed that India's cancer screening coverage also remains poor, with only 0.6% undergoing breast examination and 0.7% taking oral cavity test.

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

ICMR seeks govt panel approval to test cancer drug in WHO’s Covid Solidarity trial

The Subject Expert Committee deliberated on the matter on 9 October and asked ICMR to submit 'clarifications and justifications' for inclusion of acalabrutinib in the trial.

US approves tablet for blood cancer so patients can avoid hospital visit for chemotherapy

The drug is a combination of ‘decitabine and cedazuridine’, which are used as agents for chemotherapy. But it may not be affordable for a large section of Indian patients.

Targeted therapy can weaponise cells to kill cancer, says oncologist Siddhartha Mukherjee

Speaking at ThePrint's Off The Cuff, Dr Siddhartha Mukherjee speaks about advanced cancer treatment, its dilemmas, ethics surrounding clinical trials.

Targeting a single cell that begins tumours can revolutionise cancer treatment

If we focus our attack on energetic cancer stem cells, we may be able to directly hit the target.

On Camera

YourTurn

Representational image| File photo of students writing a test | Photo: Suraj Singh Bisht | ThePrint

More Dalit students going to Oxfords, Harvards. West now gets the caste divide

There are five primary factors driving an increasing number of students from marginalised communities entering the Western institutions.
A man counts Indian currency notes inside a shop in Mumbai, India | Reuters/Francis Mascarenhas

RBI tells state refiners to reduce dollar buying in spot market, contain sharp fall in rupee

RBI has ensured that $9 billion has been made available at overseas branches of some Indian banks for the country's three state-run refiners to tap, according to sources.

Defence

File photo of former Air Chief Marshal RKS Bhadauria after flying a MiG-21 of 51 Squadron at the Srinagar airbase | ANI

Famed IAF pilot Abhinandan Varthaman’s MiG-21 Squadron bows out from Srinagar today

Known as the ‘Sword Arms’, number-plating of the squadron was done Friday. It has made way for MiG-29s to be the new 'guardian of the Valley'.
Illustration by Soham Sen | ThePrint

AAP’s filling a big vacuum in Indian politics. Question is how long it can sustain without ideology

If you find admiration for AAP qualified, if not muted among many of the Modi-BJP’s critics, it is because they question it for its lack of ideological clarity. Especially on secularism.
×